CAR-Immune cell Manufacturing Validation Study with Pheresed Sample from Autologous/Allogenic Donors undergoing Leukapheresis for Stem cell Collection (COLLECT-4)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2028
Project Lead
Authors
Dr.Hari Menon, Dr.Ganesha , Dr.Annie K Baa
Project Status
ongoing
Project Type
St John’s Medical College Research Society